Cargando…
Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment()
OBJECTIVES: The development of rapid molecular diagnostic assays for pyrazinamide (PZA) resistance is considered technically challenging as mutations are highly diverse, scattered along the full length of the pncA gene and not all are associated with PZA resistance. We evaluated the performance of t...
Autores principales: | Driesen, M., Kondo, Y., de Jong, B.C., Torrea, G., Asnong, S., Desmaretz, C., Mostofa, K.S.M., Tahseen, S., Whitfield, M.G., Cirillo, D.M., Miotto, P., Cabibbe, A.M., Rigouts, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756542/ https://www.ncbi.nlm.nih.gov/pubmed/28587904 http://dx.doi.org/10.1016/j.cmi.2017.05.026 |
Ejemplares similares
-
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project
por: Zignol, Matteo, et al.
Publicado: (2016) -
Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance
por: Torrea, Gabriela, et al.
Publicado: (2019) -
Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter Study
por: Miotto, Paolo, et al.
Publicado: (2014) -
How To Optimally Combine Genotypic and Phenotypic Drug Susceptibility Testing Methods for Pyrazinamide
por: Köser, Claudio U., et al.
Publicado: (2020) -
Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations
por: Rigouts, L., et al.
Publicado: (2019)